CEO Of R1 Rcm Trades $6.7M In Company Stock
Gerard Joseph Flanagan, CEO at R1 Rcm (NASDAQ:RCM), made a large buy and sell of company shares on November 11, according to a new SEC filing.
Earnings Scheduled For November 2, 2021
Companies Reporting Before The Bell
• Thomson Reuters (NYSE:TRI) is expected to report quarterly earnings at $0.48 per share on revenue of $1.86 billion.
JP Morgan Initiates Coverage On R1 RCM with Overweight Rating, Announces Price Target of $27
JP Morgan analyst Anne Samuel initiates coverage on R1 RCM (NASDAQ:RCM) with a Overweight rating and announces Price Target of $27.
R1 Introduces R1 Entri Platform to Comprehensively Transform Patient Access and Experience Across Care Settings
R1 RCM Inc. (NASDAQ:RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today introduced R1 Entri™, an
R1 RCM: Q2 Earnings Insights
Shares of R1 RCM (NASDAQ:RCM) were unchanged after the company reported Q2 results.
Quarterly Results
Earnings per share were up 100.00% over the past year to $0.06, which missed the estimate of $0.07.
Earnings Scheduled For August 3, 2021
Companies Reporting Before The Bell
• Myriad Genetics (NASDAQ:MYGN) is likely to report earnings for its fourth quarter.
• Stellantis (NYSE:STLA) is expected to report earnings for its second quarter.